moderna bird flu vaccine

Order byBest matchMost fresh

HHS cancels funding for bird flu vaccine development

U.S. Cancels Contract With Moderna to Develop Bird Flu Vaccine

The Trump administration has delivered its latest blow to vaccines, canceling a nearly $600-million contract to the drugmaker Moderna that was intended to develop a shot for humans against bird flu.

· 2d

· 2d · on MSN

HHS cancels $590 million contract with Moderna for bird flu vaccine

· 23h

Trump Scraps $766 Million Moderna Deal for Bird Flu Vaccine

US FDA approves Moderna's next-generation COVID vaccine for adults 65 or older

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day.

· 14h

· 1d

The scientists aiming to stay ahead of bird flu on dairy farms and prevent a human pandemic

· 1d

Government pulls money for bird flu vaccine development over mRNA concerns

Pfizer CEO: HHS claims of ‘concealed safety concerns’ on mRNA vaccines are ‘completely inaccurate’

“We concluded that continued investment in Moderna’s H5N1 mRNA vaccine was not scientifically or ethically justifiable,” an HHS spokesperson said, claiming, “the reality is that mRNA technology remain...

· 23h

· 1d

Trump Administration Cancels $600 Million Contract to Develop Bird Flu Vaccine

· 1d

Trump Administration cancels funding for vaccine development

2don MSN

US cancels more than $700 million funding for Moderna bird flu vaccine

The Trump administration has canceled a contract awarded to Moderna for the late-stage development of its bird flu vaccine for humans, as well as the right to purchase shots, the drugmaker announced on Wednesday.

AOL2d

Moderna suffers a $750 million loss from NIH funding cut

Moderna's (MRNA) stock was up slightly in pre-market trading Thursday despite an announcement that the National Institutes of Health (NIH), led by Robert F. Kennedy Jr., is ending a $750 million-plus contract to develop its bird flu vaccine late Wednesday.

Moderna Announces Update on Investigational Pandemic Influenza Program

H5 avian flu vaccine study shows positive interim results Company has been notified that HHS will terminate Moderna’s award for late-stage development of pre-pandemic influenza vaccines CAMBRIDGE, MA / ACCESS Newswire / May 28,